Enzymtherapie – von den ersten Beobachtungen zu den aktuellen Erklärungsmodellen

Literatur

• 1 Gaschler A. Fermente und Krebs. Hippokrates 1957 2B: 68-75
• 2 Wolf M, Ransberger K. Enzymtherapie. Wien: Maudrich Verlag
• 3 Lauer D. et al . Beeinflussung der Wachstumsfaktor-bindenden Eigenschaften von a2-Makroglobulin durch Enzymtherapie.  Cancer Chemother Pharmacol. 2001;  47 (Suppl) S4-S9
• 4 Paczek L. et al . Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats.  Drugs Exp Clin Res. 2001;  27 141-149
• 5 Hollenberg M D. et al . Proteinases as hormone-like signal messengers. Proteinase-activated receptors and the pathophysiology of inflammation, pain, cardiovascular disease and cancer.  Swiss Med Wkly. 2005;  135 425-436
• 6 Misra U K. et al . Coordinate regulation of the a2-macroglobulin signaling receptor and the low density lipoprotein receptor-related protein/a2-macroglobulin receptor by Insulin.  J Biol Chem. 1999;  274 25785-25791